MANINIL MA Ọ BỤ METFORMIN: NKE KA MMA, ENWERE IKE IJIKỌTA YA

Send

Naanị dọkịta na-arụ ọrụ na nhọpụta nke ọgwụ mgbochi ọrịa, nhọrọ ahụ na-akpata ihe isi ike n'ihi nsonaazụ na contraindications.

Ọgwụ shuga dị ala, dịka Metformin na Maninil, dị iche na usoro nke ime ihe na ike nke mmetụta hypoglycemic.

Nke a bụ n'ihi ihe dị iche iche mejupụtara ọgwụ, tụlee atụmatụ ha na iche.

Ngwakọta

Metformin bụ ihe sitere n'ọtụtụ biguanides na-ebelata glucose ọbara nke ọma site na igbochi nnabata ya na imeju.

Maninyl gụnyere ihe dị n'ime glibenclamide, ihe na-ebute sulfonylurea nke ọgbọ nke abụọ nwere mmetụta na-ebelata shuga. A na-eme ọgwụ naanị na mbadamba nkume nwere ọgwụ dị iche iche nwere ike.

Omume ọgwụ

Ofkpụrụ nke Metformin bụ igbochi gluconeogenesis. Ihe ahụ na - eme ka enzyme pụrụ iche na imeju na - egbochi ọpụpụ nke glucose n'ime ọbara. Ọgwụ ahụ na-egbochi ntụgharị nke abụba ma na-akwalite oxidation ha, na-egbochi nnabata shuga na eriri afọ.

E jiri ya tụnyere ndị ọrụ hypoglycemic ndị ọzọ, ọgwụ ahụ kacha arụ ọrụ iji gbochie mmepe nke ọrịa angiopathy. Iji usoro eji eme ihe, ọgwụ ahụ na-egbochi ịba ụba, ma mgbe ị na-eri nri, ọ na - enyere aka belata ya.

Mbadamba ụrọ Metformin

Ọgwụ ahụ na-egbochi mmepe nke insulin na-egbochi ma na-eme ka mmadụ nwee ike ịmịcha glucose n'ime akwara mmadụ. Ebe ume insulin na ọbara, ihe ndị dị na ya anaghị egosipụta ihe hypoglycemic.

Maninyl na-akpali mmepụta nke insulin na pancreas n'ihi mmechi nke ọwa potassium na sel beta. Ọdịnaya nke potassium ion na-abawanye, nke na-enye pancreas akara iji mepụta insulin ọhụrụ.

N'oge ọgwụgwọ glibenclamide (Maninil), ịchịkwa shuga ọbara dị mkpa, ike nke ọgwụ ahụ dabere na oke eji. Site n'iji ojiji a na-ejikọta ya na biguanide, ihe ize ndụ nke ịmalite hypoglycemia na-abawanye nke ukwuu, yabụ, a na-ebelata dose nke glibenclamide.

Ogwu ahụ nwere ike ime ka nzaghachi metabolic na hormone ahụ dị, belata ihe ize ndụ nke nephropathy na ọnwụ. Usoro ihe a na-ejikọ emetụtaghị glucose n'ọbara, ya mere, ọgwụ ahụ na-arụ ọrụ ọbụlagodi normoglycemia.

Ihe ngosi

Ejiri Metformin dịka onye na-ahụ maka hypoglycemic bụ nke kachasị maka ụdị shuga 2.

Typedị ọrịa shuga 1, enwere ike ịkọ ọgwụ dịka ọgwụ mgbochi maka mmepe nke ọrịa angiopathy.

Enwere ike iji ọgwụ hypoglycemic mee ihe maka polycystic ovary, ma ọ bụrụ na achọpụta hyperinsulinemia na ndidi glucose.

A na-eji Glibenclamide naanị maka ụdị ọrịa shuga nke 2, mgbe ị na-eji nri dị mma na ibu zuru oke, ọ gaghị ekwe omume belata glucose ọbara.

Enwere m ike iwere ya?

Considertụle enwere ike ị combinationụkọta ọgwụ ọnụ, ị ga-eburu n'uche atụmatụ nke oriri ha na mmekọrịta nke ihe ndị na - arụ ọrụ.

Mmetụta na -ebelata shuga nke glibenclamide na-adabere na usoro onunu ogwu: karie ka ọ dị, ka ukwuu na-enwe mmetụta na pancreas.

Mgbe ihe ndị na-arụ ọrụ kpaliri, a na-amalite imepụta insulin ọzọ, yabụ nhọrọ nke ọgwụ Maninil chọrọ ka a na-ekpebi site n’ọbara shuga.

Mgbe ị na-ede ọgwụ, dọkịta ga-enyerịrị ndụmọdụ banyere nri ma na-eburu ego nke carbohydrates dị na nri. N'ime usoro izizi, usoro ọgwụgwọ na-ebido site na usoro dị ala kachasị dị mma, mgbe nchịkwa gasịrị, a na-achọpụta mmetụta na ndị ọrịa mamịrị.

Ọ bụrụ na ọ dị mkpa, mee ka ọgwụ ahụ dịkwuo elu. Were ọgwụ 1-2 ugboro n'ụbọchị, mmetụta nke ihe na-arụ ọrụ bụ opekata mpe awa iri na abụọ.

Iji mee ka mmetụta hypoglycemic dị elu ma belata oriri nke carbohydrates n'ọbara, nchịkwa nke Maninil na Metformin n'otu oge ga-ekwe omume.

A na-eji ọgwụ ndị a gwakọtara ọnụ mgbe ọ gaghị ekwe omume inweta ọgwụgwọ ọgwụgwọ dị mkpa.

Ekwesịrị itinye ọgwụ ọzọ maka ọgwụ antidiabet ka dọkịta gwọọ. Na njikọta na ọgwụ ndị ọzọ, a na-eme ka mmetụta nke glibenclamide na ahụ dịkwuo mma.

Site na nhọrọ na-ezighi ezi nke ọgwụ a, hypoglycemia nwere ike ịmalite.

Kedu nke ka mma?

Mgbe ị na-edepụta onye na - ahụ maka hypoglycemic, ha na - eduzi mmetụta ọgwụgwọ chọrọ, usoro nke ihe mejupụtara akụrụngwa, contraindications dị ugbu a maka ojiji na mmetụta.

Metformin ma ọ bụ Maninil

Otu njiri mara nke Metformin bụ na mmetụta hypoglycemic na ahụ adịghị emetụta ntụtụ insulin. Principlekpụrụ nke ọgwụ bụ imechi usoro glucose dị elu.

Metformin bụ otu n'ime ọgwụ ole na ole nwere ihe ize ndụ nke ịmalite hypoglycemia dị ntakịrị. Na mgbakwunye na nrịanrịa nke eriri afọ, ọgwụ ahụ enweghị obere ihe ọ bụla. Lactic acidosis nwere ike ịdabara ya na nnukwu oke onodu ma ọ bụrụ na akụrụ gbasara ezumike.

Ọgwụ Maninil

Ya mere, site n'ịmepụta ọgwụ hormone nke peptide site na pancreas, mana na-egbochi insulin dị elu, a na-ahọrọ Metformin ka mma.

E guzobela na biguanide nwere ike belata oke ihe ọghọm nke ịrịa ọrịa na-arịa ọrịa shuga.

Ihe ọghọm ya gụnyere eziokwu ahụ bụ na biguanide enweghị ike belata shuga site na ụkọ insulin na ahụ. Ogologo oge ị ofụ ọgwụ ahụ na-egbochi ịmịpụta vitamin B12, nke nwere ike imecha mee ka mmepe nke myalgia na anaemia.

Edere Glibenclamide naanị maka ụdị ọrịa mamịrị 2, mgbe mmetụta nke mbadamba shuga ndị ọzọ ezughị.

Ngwongwo sulfonylurea (glibenclamide) nwere otutu nsogbu ndi ozo:

ọ bụrụ na ego nke ihe na-arụ ọrụ akarị, hypoglycemia siri ike nwere ike ịmalite;
uru dị arọ;
nkwonkwo mgbu
isi ọwụwa
mụbaa na ọkụ;
ahụ ọkụ
nsogbu nri;
ike ọgwụgwụ;
proteinuria (protein na-apụta na mmamịrị);
ọrịa cholestatic;
mmeghachi omume nfụkasị ahụ;
ugboro ugboro.

Maninil nwere mmetụta hypoglycemic siri ike, mana enwere ndepụta dị egwu maka mmetụta ndị ọzọ.

Ndepụta ọgwụ contraindications maka ọgwụ ọgwụ niile bụ otu, belụsọ na glibenclamide machibidoro ịlyụ ọrịa shuga na-akpata insulin.

Enweghị ike iji Metformin, Maninil mee ihe n'ọnọdụ:

ọrịa shuga;
ime
lactation;
imebi imeju na akụrụ;
ọdịdị ketoacidosis;
hypersensitivity.

Enwere ike iji Glibenclamide kpachara anya na mmanya, nke maka biguanide bụ mmachi kpam kpam.

Na mgbakwunye, a na-akagbu Metformin ụbọchị abụọ tupu x-ray na mgbe ray gasịrị, ma ọ bụrụ na enwere mmeghe nke iodinated iche.

Maninil ma ọ bụ Amaryl

Amaryl bụ hypoglycemic nke dabeere na sulfonylureas nke ọgbọ III. Nwere ihe ndị na - arụ ọrụ - glimepiride. Ofkpụrụ nke ime ihe bụ ịkpalite mwepụta nke insulin na-agwụ ike.

Mbadamba amaryl

N'adịghị ka Maninil, Amaryl nwere mmetụta ọzọ - ọgwụ ahụ na-egbochi gluconeogenesis. A na-ekwupụta mmetụta hypoglycemic nke Amaril ma ọ dịkarịa ala awa 24.

Site na nchịkwa insulin n'otu oge, a pụrụ iji ihe karịrị otu ụzọ n’ụzọ atọ belata ọ̀tụ̀tụ̀ homonụ dị n’etiti ndị ọrịa buru ibu.

Enweghị ike ịkọwa Maninil na Amaril maka ụdị ọrịa shuga na-adabere na ọrịa shuga. Mgbe ị na-ahọrọ otu ọgwụ nke Amaril na usoro ọgwụgwọ ọzọ, a ga-eburu ọgụgụ ọgụgụ ọbara ọbara, ebe enwere ike ịmepụta hypoglycemia.

Ngosiputa ihe ojoo site na iji ogwu na contraindications abughi ihe di iche. Ewepu ya bụ ọrịa akpọrọ akpọ akpọ akpọ na Amaril, nke metụtara usoro iji gbochie gluconeogenesis nke ọgwụ.

Vidiyo ndị metụtara

Ofzọ nke ime ihe, ụdị mwepụta na nuances nke iji Metformin na vidiyo ahụ:

Maninil na Amaryl nwere mmetụta hypoglycemic siri ike, mana enwere ndepụta dị egwu nke mmetụta ndị ọzọ. Ọ bụrụ na a chọghị ime ka ihe puru iche mee ihe iji mepụta insulin.

Metformin nwere uru doro anya. Ọ ruo n’ọ̀tụ̀tụ̀ dị ukwuu na-ebelata ihe ize ndụ nke atherosclerosis, adịghị eduga n’inwe ibu ma gbochie mmepe nke ọrịa obi. Nsonaazụ sitere na ngwara nri site na iwere biguanide ngwa ngwa.

Send